- Home
- CCTG vs CURX Comparison
CCTG vs CURX Comparison
Compare CCTG & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCTG | CURX |
|---|---|---|
| Founded | 1993 | 2018 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7M | 29.7M |
| IPO Year | 2024 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CCTG | CURX |
|---|---|---|
| Price | $0.13 | $0.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 618.1K | ★ 2.7M |
| Earning Date | 12-23-2025 | 09-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,878,618.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.52 | N/A |
| 52 Week Low | $0.12 | $3.61 |
| 52 Week High | $2.61 | $8.60 |
Technical Indicators
Market Signals| Indicator | CCTG | CURX |
|---|---|---|
| Relative Strength Index (RSI) | 28.67 | N/A |
| Support Level | $0.12 | N/A |
| Resistance Level | $0.21 | N/A |
| Average True Range (ATR) | 0.03 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 9.60 | 0.00 |
Price Performance
Historical ComparisonAbout CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.
About CURX Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.